Nete Tofte
Nete Tofte
Steno Diabetes Center Copenhagen
Verified email at regionh.dk
Title
Cited by
Cited by
Year
Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational …
N Tofte, M Lindhardt, K Adamova, SJL Bakker, J Beige, JWJ Beulens, ...
The Lancet Diabetes & Endocrinology 8 (4), 301-312, 2020
512020
Utility of plasma concentration of trimethylamine N-oxide in predicting cardiovascular and renal complications in individuals with type 1 diabetes
SA Winther, JC Øllgaard, N Tofte, L Tarnow, Z Wang, TS Ahluwalia, ...
Diabetes care 42 (8), 1512-1520, 2019
372019
Use of prophylactic voriconazole for three months after lung transplantation does not reduce infection with Aspergillus: a retrospective study of 147 patients
N Tofte, C Jensen, M Tvede, CB Andersen, J Carlsen, M Iversen
Scandinavian journal of infectious diseases 44 (11), 835-841, 2012
322012
Uric acid is an independent risk factor for decline in kidney function, cardiovascular events, and mortality in patients with type 1 diabetes
S Pilemann-Lyberg, TW Hansen, N Tofte, SA Winther, S Theilade, ...
Diabetes Care 42 (6), 1088-1094, 2019
292019
Characteristics of high‐and low‐risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in …
N Tofte, M Lindhardt, K Adamova, J Beige, JWJ Beulens, AL Birkenfeld, ...
Diabetic Medicine 35 (10), 1375-1382, 2018
212018
Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes
N Tofte, T Suvitaival, L Ahonen, SA Winther, S Theilade, M Frimodt-Møller, ...
Scientific reports 9 (1), 1-10, 2019
202019
Metabolomic assessment reveals alteration in polyols and branched chain amino acids associated with present and future renal impairment in a discovery cohort of 637 persons …
N Tofte, T Suvitaival, K Trost, IM Mattila, S Theilade, SA Winther, ...
Frontiers in endocrinology 10, 818, 2019
162019
Chronic urinary tract infections in patients with spinal cord lesions–biofilm infection with need for long‐term antibiotic treatment
N Tofte, ACY Nielsen, H Trøstrup, CB Andersen, M Von Linstow, ...
Apmis 125 (4), 385-391, 2017
152017
Markers of collagen formation and degradation reflect renal function and predict adverse outcomes in patients with type 1 diabetes
S Pilemann-Lyberg, DGK Rasmussen, TW Hansen, N Tofte, SA Winther, ...
Diabetes Care 42 (9), 1760-1768, 2019
142019
Soluble urokinase plasminogen activator receptor predicts cardiovascular events, kidney function decline, and mortality in patients with type 1 diabetes
VR Curovic, S Theilade, SA Winther, N Tofte, J Eugen-Olsen, F Persson, ...
Diabetes Care 42 (6), 1112-1119, 2019
122019
Plasma metabolomics identifies markers of impaired renal function: a meta-analysis of 3089 persons with type 2 diabetes
N Tofte, N Vogelzangs, D Mook-Kanamori, A Brahimaj, J Nano, ...
The Journal of Clinical Endocrinology & Metabolism 105 (7), 2275-2287, 2020
72020
Changes in diabetes distress among people with type 2 diabetes during a risk screening programme for diabetic kidney disease–longitudinal observations of the PRIORITY study
LE Joensen, KP Madsen, M Frimodt-Møller, N Tofte, I Willaing, ...
Journal of diabetes and its complications 34 (1), 107467, 2020
52020
Visit‐to‐visit variability of clinical risk markers in relation to long‐term complications in type 1 diabetes
V Rotbain Curovic, S Theilade, SA Winther, N Tofte, L Tarnow, A Jorsal, ...
Diabetic Medicine 38 (5), e14459, 2021
22021
Copeptin and renal function decline, cardiovascular events and mortality in type 1 diabetes
NS Heinrich, S Theilade, SA Winther, N Tofte, TS Ahluwalia, JL Jeppesen, ...
Nephrology Dialysis Transplantation, 2020
12020
Carotid‐Femoral Pulse Wave Velocity as a Risk Marker for Development of Complications in Type 1 Diabetes Mellitus
NH Tougaard, S Theilade, SA Winther, N Tofte, TS Ahluwalia, TW Hansen, ...
Journal of the American Heart Association 9 (19), e017165, 2020
12020
Omics research in diabetic kidney disease: new biomarker dimensions and new understandings?
N Tofte, F Persson, P Rossing
Journal of Nephrology 33, 931-948, 2020
12020
Baseline characteristics in PRIORITY study: proteomics and miner-alocorticoid receptor antagonism for prevention of diabetic nephropathy in type 2 diabetes
N Tofte
DIABETOLOGIA 60, S484-S485, 2017
12017
Comparison of Natriuretic Peptides as Risk Markers for All-Cause Mortality and Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes
N Tofte, S Theilade, SA Winther, S Birkelund, JP Goetze, TW Hansen, ...
Diabetes care 44 (2), 595-603, 2021
2021
Cardiovascular autonomic dysfunction is a risk marker of future decline in kidney function in type 1 diabetes
T Bjerre-Christensen, SA Winther, N Tofte, S Theilade, TS Ahluwalia, ...
DIABETOLOGIA 63 (SUPPL 1), S388-S388, 2020
2020
Metabolites of the mitochondrial energy production are associated with future cardiovascular morbidity and mortality in type 1 diabetes
N Tofte, T Suvitaival, K Trost, IM Mattila, S Theilade, SA Winther, ...
DIABETOLOGIA 63 (SUPPL 1), S447-S447, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20